AI-guided pre-surgery treatment for pancreatic cancer
Treatments studied
Part of Cancer clinical trials.
This study tests how well an AI tool can guide which pre-surgery treatment is best for people with pancreatic cancer that can be removed. It uses your tumor's genetic fingerprint to choose the most effective therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your pancreatic tumor is borderline resectable or can be removed with surgery (no spread).
- You have stored tumor tissue from a biopsy already done.
- You are active enough to do light work or daily chores (ECOG 0 or 1).
- You have not had chemotherapy or other treatment for this cancer yet.
- You don't have another cancer being treated right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at specific body chemistry pathways in pancreatic cancer tissue to better understand what may help treatment work. If you are having pancreatic surgery, the researchers will take extra small tissue samples during the operation to study tumor and normal tissue.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
This trial uses artificial intelligence to analyze routine CT scans of the chest or abdomen (done for other reasons) to detect early signs of pancreatic cancer. If you are already getting a CT scan for another health issue, this could help catch pancreatic cancer early without extra tests.
This trial tests whether a blood test that detects tumor DNA can help doctors decide early if the standard chemotherapy is working, and if switching treatment might be better. It is for people newly diagnosed with metastatic pancreatic cancer who are starting their first chemotherapy.
This study uses artificial intelligence (AI) to help doctors make better decisions for people with suspected pancreatic conditions. If you are already getting a special CT scan, the AI will analyze the images to see if it can improve diagnosis and treatment planning.
This trial is for people who had surgery for pancreatic cancer and are now deciding on maintenance therapy. A special blood test (ctDNA) may help doctors choose the best follow-up treatment to prevent the cancer from coming back.
Hear when a new Pancreatic Ductal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.